Scientists at Biomodels have successfully developed the first model that accurately duplicates human cancer treatment-related fatigue (CTRF). The new model shows that, as in human cancer patients, fatigue is independent of anaemia or weight loss and persists long after cancer treatments end.
The new model and research findings were presented at the American Association for Cancer Research-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting in Boston.
Lingering fatigue is a debilitating problem in patients who have been treated for cancer and its etiology is poorly understood. Fat…
Further information:
Related posts:
- 2007 EORTC-NCI-ASCO Annual Meeting: Molecular Markers in Cancer
- Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome
- VAI researchers develop tool to help study prostate cancer
- Researchers find that sociodemographic characteristics are related to a patient’s willingness to participate in cancer screenings
- The Mouse With A Human Liver: A New Model For The Treatment Of Liver Disease
Posted in